Skip to main content

Table 1 Study schedule. MADRS and HAM-D at V0 are part of usual care of the included patients

From: Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)

Criteria

Selection: Psychiatry consultation or hospitalization

Visit V0: Psychiatry 0–20 days after decision of drug dosage increase

Visit V1: With a nurse Period: 7–21 days after V0

Visit V2: With a Psychologist or a pratictionner: 25–40 days (4 weeks) after V0

Visit V3: With a Psychologist or a pratictionner: 50–70 days (8 weeks) after V0

Oral and written Information about the protocol

MARVEL

MARVEL

   

Verification of inclusion and non inclusion criteria, Signature of informed consent

MARVEL

MARVEL

   

MADRS and HAM-D

 

Usual care

 

MARVEL

MARVEL

Screen for tobacco use

 

MARVEL

   

Renal and liver function

 

MARVEL

   

Characteristics of the mood disorder

 

MARVEL

   

Anxiety scale Tyrer

 

MARVEL

   

Criteria for rating medication trials for antidepressant failure

 

MARVEL

   

QIDS-score

 

MARVEL

 

MARVEL

MARVEL

MARS score

 

MARVEL

 

MARVEL

MARVEL

PRISE-M score

 

MARVEL

 

MARVEL

MARVEL

FIBSER score

 

MARVEL

 

MARVEL

MARVEL

Urinary pregnancy test

  

MARVEL

  

Current treatment

 

MARVEL

MARVEL

MARVEL

MARVEL

Recent alimentation

  

MARVEL

  

Blood sample for Css of V and ODV, and mRNA

  

MARVEL

  

Cocktail of drugsa administration

  

MARVEL

  

Blood sample for Phenotypic study

  

MARVEL

  

Total amount of blood for the research

Visit 1 only: 12.5 mL of venous blood and 3 drops of capillary blood sample

  1. afexofenadine, midazolam, dextromethorphan, omeprazole
  2. MADRS (Montgomery and Asberg Depression Rating Scale), HAM-D (Hamilton Rating Scale for Depression), QIDS (Quick Inventory of Depressive Symptomatology), MARS (score Medication Adherence Report Scale), PRISE-M (Patient Rated Inventory of Side Effects), FIBSER (Frequency, Intensity, and Burden of Side Effects Ratings), V (Venlafaxine), ODV (O-demethyl-Venlafaxine)